Rimonabant, a Selective Cannabinoid CB1 Receptor Antagonist, Inhibits Atherosclerosis in LDL Receptor–Deficient Mice
2009 ◽
Vol 29
(1)
◽
pp. 12-18
◽
2007 ◽
Vol 32
(12)
◽
pp. 2592-2600
◽
2000 ◽
Vol 387
(1)
◽
pp. 47-53
◽
2009 ◽
Vol 104
(6)
◽
pp. 781-792
◽
6ʺ-Azidohex-2ʺ-yne-cannabidiol: a potential neutral, competitive cannabinoid CB1 receptor antagonist
2004 ◽
Vol 487
(1-3)
◽
pp. 213-221
◽